Must Read Rumors

Prince Harry and Meghan Markle are “total homebodies” at Kensington Palace

Prince Harry is always on the road for his royal engagements. His girlfriend Meghan Markle is also busy as an actress. But in between they manage to make time to see each other.

Kate Middleton and Prince William will take George and Charlotte on royal tour of Poland and Germany

Prince George and Princess Charlotte will accompany the Duke and Duchess of Cambridge on their upcoming European tour.

Duchess Kate debuts new haircut at Wimbledon

Prince William’s wife appeared at Wimbledon with a new elegant and refined haircut that didn’t go unnoticed.

Kate Middleton to attend opening of Wimbledon tennis championships

An avid tennis fan for many years, the Duchess of Cambridge, née Kate Middleton, will be present on the first day of the Wimbledon Championships this year.

Kate Middleton reveals mom Carole Middleton’s crush on Roger Federer

The Duchess of Cambridge, née Kate Middleton, was invited to participate in a documentary about tennis and she made some revelations about her parents during the interview.

Prince Harry and Meghan Markle are “total homebodies” at Kensington Palace
Kate Middleton and Prince William will take George and Charlotte on royal tour of Poland and Germany
Duchess Kate debuts new haircut at Wimbledon
Kate Middleton to attend opening of Wimbledon tennis championships
Kate Middleton reveals mom Carole Middleton’s crush on Roger Federer

A new plan for a drug against HIV

by Julia
August 22, 2011 at 1:12 am

A new drug that causes HIV to mutate could eventually entirely eliminate the virus in people suffering from it.

The discovery of a drug to cure HIV is a large-scale business. Currently, the market for HIV drugs has reached $ 14 billion, which means $ 600,000 to treat a single patient.

These drugs are designed to suppress and prevent virus propagation, but have many disadvantages, including cost, side effects and that patients depend on them for life.

Koronis Pharmaceuticals, a biotechnology company, has found a possible solution with KP-1461, a new drug that causes mutations in cells affected by HIV. If it will work, patients could get off the drug and recover from AIDS.

KP-1461 uses a new mechanism, called Viral Decay Acceleration T, to insert itself into the viral genome and accelerate the frequency of mutations until the virus collapses.

“If you think of HIV as a house made of two by fours, and the genetic backbone of the virus as the foundation of that house, [the drug mechanism] replaces the two by fours with toothpicks, and eventually the house comes crashing down,” said Dr. Mark G. Fromhold, VP of Manufacturing and Business Development at Koronis.

Until now, the company has successfully tested the drug in the laboratory. testing patients will be much harder but it could be a breakthrough dicovery.

The downside is that patients will have to take the medication for a long time. In the second stage of tests, Koronis will use a combination of therapies and will measure the exact time that the healing of the patients takes. The company wants to raise $ 15 million from business partners for further study.

Filled under: ,

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions